Patents Assigned to RXCELL INC.
  • Method for generating multiple cellular products from single pluripotent cell source
    Patent number: 11946069
    Abstract: Methods are provided for generating multiple cellular products via differentiation of cells from single clinically compliant pluripotent cells into multiple cellular products selected from retinal epithelium, retinal progenitors, neural stem cells, dopaminergic neurons, astrocytes, hepatocytes, endothelial cells and mesenchymal cells using standard differentiation protocols for the multiple cellular products.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: April 2, 2024
    Assignee: RxCell, Inc.
    Inventors: Xianmin Zeng, Mahendra Rao
  • Methods and compositions for rapid generation of single and multiplexed reporters in cells
    Patent number: 11530389
    Abstract: Methods and compositions for rapid development of reporter lines utilizing safe harbor sites in iPSCS, as well as other progenitor cells, pluripotent and multipotent stem cells and differentiated cells, and multiple Lox sites are provided.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: December 20, 2022
    Assignee: RXCELL INC.
    Inventors: Xianmin Zeng, Mahendra S. Rao
  • Methods and compositions for rapid generation of single and multiplexed reporters in cells
    Patent number: 10787644
    Abstract: Methods and compositions for rapid development of reporter lines utilizing safe harbor sites in iPSCS, as well as other progenitor cells, pluripotent and multipotent stem cells and differentiated cells, and multiple Lox sites are provided.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: September 29, 2020
    Assignee: RXCELL INC.
    Inventors: Xianmin Zeng, Mahendra S. Rao